Nguyen, T.M.; Joyce, P.; Ross, D.M.; Bremmell, K.; Jambhrunkar, M.; Wong, S.S.; Prestidge, C.A.
Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax. Pharmaceutics 2024, 16, 209.
https://doi.org/10.3390/pharmaceutics16020209
AMA Style
Nguyen TM, Joyce P, Ross DM, Bremmell K, Jambhrunkar M, Wong SS, Prestidge CA.
Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax. Pharmaceutics. 2024; 16(2):209.
https://doi.org/10.3390/pharmaceutics16020209
Chicago/Turabian Style
Nguyen, Thao M., Paul Joyce, David M. Ross, Kristen Bremmell, Manasi Jambhrunkar, Sook S. Wong, and Clive A. Prestidge.
2024. "Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax" Pharmaceutics 16, no. 2: 209.
https://doi.org/10.3390/pharmaceutics16020209
APA Style
Nguyen, T. M., Joyce, P., Ross, D. M., Bremmell, K., Jambhrunkar, M., Wong, S. S., & Prestidge, C. A.
(2024). Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax. Pharmaceutics, 16(2), 209.
https://doi.org/10.3390/pharmaceutics16020209